|
2018 |
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. |
Patrick T Ronaldson, PhD, FAAPS |
|
2018 |
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery. |
Thomas P Davis, PhD, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain. |
Tally Largent-Milnes, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
|
2017 |
Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria. |
|
|
2017 |
Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Synthetic analogues of cyanobacterial alkaloid cylindrospermopsin and their toxicological activity. |
Christopher Cartmell |
|
2017 |
Blocking CRMP2 SUMOylation reverses neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism. |
Nam Lee, Ph.D. |
|
2017 |
Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. |
Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. |
John M. Streicher, PhD |
|
2017 |
Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy. |
Nam Lee, Ph.D. |
|
2017 |
Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain. |
John M. Streicher, PhD |
|
2017 |
Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. |
Frank Porreca, PhD |
|
2017 |
Remote Ischemic Conditioning Preserves Cognition and Motor Coordination in a Mouse Model of Traumatic Brain Injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke. |
|
|
2017 |
Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers. |
John M. Streicher, PhD |
|
2017 |
Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice. |
John M. Streicher, PhD |
|
2017 |
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. |
John M. Streicher, PhD |
